Opiate AH-7921 Added to Schedule I Under Single Convention on Narcotic Drugs, 1961

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Scheduling

Opiate AH-7921 Added to Schedule I Under Single Convention on Narcotic Drugs, 1961

Ken Baumgartner

April 18, 2016 at 04:56:00 ET

Following notification from the United Nations Commission on Narcotic Drugs, the opiate AH-7921 was placed in Schedule I of the Controlled Substances Act with an effective date of May 16 (81 Fed. Reg. 22023; April 14, 2016). AH-7921 is an N-substituted cyclohexylmethyl benzamide developed in 1962. It acts as a micro-opioid receptor agonist with analgesic activity similar to that o... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Opiate AH-7921 Added to Schedule I Under Single Convention on Narcotic Drugs, 1961

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT